(Q40605226)

22 September 2017

title

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma (English)

1 reference

22 September 2017

1 reference

1 reference

1 reference

9

Lippman SM

1 reference

22 September 2017

8

Ang KK

1 reference

22 September 2017

Shin DM

1

1 reference

22 September 2017

Khuri FR

2

1 reference

22 September 2017

Glisson BS

3

1 reference

22 September 2017

Ginsberg L

4

1 reference

22 September 2017

Papadimitrakopoulou VM

5

1 reference

22 September 2017

Clayman G

6

1 reference

22 September 2017

Lee JJ

7

1 reference

22 September 2017

Hong WK

10

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

22 September 2017

1 reference

22 September 2017

volume

91

1 reference

22 September 2017

issue

7

1 reference

22 September 2017

page(s)

1316-1323

1 reference

22 September 2017

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

Optimal two-stage designs for phase II clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

Phase I/II study of cisplatin, 5-fluorouracil and alpha-interferon for recurrent carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

Paclitaxel-induced neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

Motor neuropathy due to docetaxel and paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

Paclitaxel-induced severe neuropathy in patients with previous radiotherapy to the head and neck region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010401%2991%3A7%3C1316%3A%3AAID-CNCR1134%3E3.0.CO%3B2-0

10.1002/1097-0142(20010401)91:7<1316::AID-CNCR1134>3.0.CO;2-0

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference